180 related articles for article (PubMed ID: 37561810)
1. Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
Massud A; Khan AH; Syed Sulaiman SA; Ahmad N; Shafqat M; Ming LC
PLoS One; 2023; 18(8):e0287966. PubMed ID: 37561810
[TBL] [Abstract][Full Text] [Related]
2. High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis.
Naz F; Ahmad N; Wahid A; Ahmad I; Khan A; Abubakar M; Khan SA; Khan A; Latif A; Ghafoor A
BMC Infect Dis; 2021 Dec; 21(1):1209. PubMed ID: 34863099
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.
Khan FU; Rehman AU; Khan FU; Hayat K; Khan A; Ahmad N; Chang J; Malik UR; Fang Y
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162598
[TBL] [Abstract][Full Text] [Related]
4. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan.
Khan I; Ahmad N; Khan S; Muhammad S; Ahmad Khan S; Ahmad I; Khan A; Gulalai ; Atif M
J Infect Public Health; 2019; 12(6):809-815. PubMed ID: 31056438
[TBL] [Abstract][Full Text] [Related]
6. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
[TBL] [Abstract][Full Text] [Related]
7. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes among multidrug-resistant TB patients in Bahawal Victoria Hospital, Bahawalpur, Pakistan: a retrospective record review.
Atif M; Ahmad W; Ahmad N; Malik I; Sarwar S
Trans R Soc Trop Med Hyg; 2020 Oct; 114(10):733-741. PubMed ID: 32556195
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.
Wahid A; Ahmad N; Ghafoor A; Latif A; Saleem F; Khan S; Atif M; Iqbal Q
Am J Trop Med Hyg; 2021 Mar; 104(5):1784-1791. PubMed ID: 33724924
[TBL] [Abstract][Full Text] [Related]
10. Treatment Outcomes of Childhood Tuberculosis in Three Districts of Balochistan, Pakistan: Findings from a Retrospective Cohort Study.
Abdullah A; Ahmad N; Atif M; Khan S; Wahid A; Ahmad I; Khan A
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32647882
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.
Javaid A; Khan MA; Jan F; Rauf M; Khan MA; Basit A; Mehreen S
Tuberk Toraks; 2018 Mar; 66(1):16-25. PubMed ID: 30020037
[TBL] [Abstract][Full Text] [Related]
12. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.
Ahmad N; Javaid A; Basit A; Afridi AK; Khan MA; Ahmad I; Sulaiman SA; Khan AH
Int J Tuberc Lung Dis; 2015 Sep; 19(9):1109-14, i-ii. PubMed ID: 26260834
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance.
Hameed S; Ahmad SR; Rahman MAU; Nazir H; Ullah I
J Glob Antimicrob Resist; 2019 Sep; 18():155-159. PubMed ID: 30910744
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.
Ahmad T; ; Khan M; Khan MM; Ejeta E; Karami M; Ohia C
Int J Mycobacteriol; 2017; 6(4):360-364. PubMed ID: 29171450
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.
Khan MA; Mehreen S; Basit A; Khan RA; Jan F; Ullah I; Ihtesham M; Khan A; Ullah U; Javaid A
Saudi Med J; 2015 Dec; 36(12):1463-71. PubMed ID: 26620989
[TBL] [Abstract][Full Text] [Related]
18. Predictors of unsuccessful tuberculosis treatment outcomes in children from a prospective cohort study in Pakistan.
Brooks MB; Malik A; Khan S; Ahmed JF; Siddiqui S; Jaswal M; Saleem S; Amanullah F; Becerra MC; Hussain H
J Glob Health; 2021 Feb; 11():04011. PubMed ID: 33692895
[TBL] [Abstract][Full Text] [Related]
19. Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.
Ullah I; Javaid A; Tahir Z; Ullah O; Shah AA; Hasan F; Ayub N
PLoS One; 2016; 11(1):e0147529. PubMed ID: 26809127
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country.
Wahid A; Ghafoor A; Khan AW; Al-Worafi YM; Latif A; Shahwani NA; Atif M; Saleem F; Ahmad N
Front Pharmacol; 2022; 13():973713. PubMed ID: 36160454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
